Alpha pharma: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Alpha pharma
Largest movements
- Tangible fixed assets +€203,581
up €203,581 (+29.1%), from €699,182 to €902,763
of which Land and buildings: +€201,992
- Receivables within one year +€34,513
up €34,513 (+21.2%), from €162,745 to €197,258
of which Trade receivables: +€44,155
- Stocks and contracts -€24,877
down €24,877 (-12.0%), from €207,658 to €182,781
- Other debts +€134,578
up €134,578 (+59.2%), from €227,195 to €361,773
- Profit (loss) carried forward +€46,498
up €46,498 (+20.2%), from €230,304 to €276,801
- Debts after one year -€46,301
down €46,301 (-20.4%), from €226,861 to €180,560
- Trade debts +€45,835
up €45,835 (+30.0%), from €152,589 to €198,424
- Tax, wage and social debts +€16,726
up €16,726 (+71.0%), from €23,543 to €40,269
of which Remuneration and social security: +€12,154
- Staff costs +€47,596
up €47,596 (+53.0%), from €89,720 to €137,316
- Gross operating margin +€43,912
up €43,912 (+14.2%), from €308,603 to €352,515
- Taxes -€7,365
down €7,365 (-16.3%), from €45,088 to €37,724
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,248,645 | €1,454,866 | +€206,222 | +16.5% |
| Fixed assets | 21/28 | €700,176 | €903,218 | +€203,042 | +29.0% |
| Intangible fixed assets | 21 | €995 | €455 | -€539 | -54.2% |
| Tangible fixed assets | 22/27 | €699,182 | €902,763 | +€203,581 | +29.1% |
| Land and buildings | 22 | €683,677 | €885,670 | +€201,992 | +29.5% |
| Plant, machinery and equipment | 23 | €5,691 | €3,526 | -€2,165 | -38.0% |
| Furniture and vehicles | 24 | €9,728 | €5,098 | -€4,630 | -47.6% |
| Other tangible fixed assets | 26 | €85 | €8,470 | +€8,385 | +9,823% |
| Current assets | 29/58 | €548,468 | €551,648 | +€3,180 | +0.6% |
| Stocks and contracts in progress | 3 | €207,658 | €182,781 | -€24,877 | -12.0% |
| Stocks | 30/36 | €207,658 | €182,781 | -€24,877 | -12.0% |
| Amounts receivable within one year | 40/41 | €162,745 | €197,258 | +€34,513 | +21.2% |
| Trade receivables | 40 | €140,977 | €185,133 | +€44,155 | +31.3% |
| Other amounts receivable | 41 | €21,768 | €12,125 | -€9,642 | -44.3% |
| Cash at bank and in hand | 54/58 | €174,724 | €168,312 | -€6,412 | -3.7% |
| Deferred charges and accrued income | 490/1 | €3,341 | €3,297 | -€44 | -1.3% |
| Total equity and liabilities | 10/49 | €1,248,645 | €1,454,866 | +€206,222 | +16.5% |
| Equity | 10/15 | €569,000 | €627,122 | +€58,122 | +10.2% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €320,096 | €331,720 | +€11,624 | +3.6% |
| Tax-exempt reserves | 132 | €124 | €124 | = | 0.0% |
| Distributable reserves | 133 | €319,972 | €331,597 | +€11,624 | +3.6% |
| Profit (loss) carried forward | 14 | €230,304 | €276,801 | +€46,498 | +20.2% |
| Amounts payable | 17/49 | €679,645 | €827,744 | +€148,100 | +21.8% |
| Amounts payable after more than one year | 17 | €226,861 | €180,560 | -€46,301 | -20.4% |
| Financial debts | 170/4 | €226,861 | €180,560 | -€46,301 | -20.4% |
| Amounts payable within one year | 42/48 | €452,784 | €647,185 | +€194,401 | +42.9% |
| Current portion of amounts payable after more than one year | 42 | €49,033 | €46,301 | -€2,732 | -5.6% |
| Trade debts | 44 | €152,589 | €198,424 | +€45,835 | +30.0% |
| Suppliers | 440/4 | €152,589 | €198,424 | +€45,835 | +30.0% |
| Advances received on contracts in progress | 46 | €424 | €417 | -€6 | -1.5% |
| Taxes, remuneration and social security | 45 | €23,543 | €40,269 | +€16,726 | +71.0% |
| Taxes | 450/3 | €12,088 | €16,660 | +€4,572 | +37.8% |
| Remuneration and social security | 454/9 | €11,455 | €23,609 | +€12,154 | +106% |
| Other amounts payable | 47/48 | €227,195 | €361,773 | +€134,578 | +59.2% |
| Remuneration, social security and pensions | 62 | €89,720 | €137,316 | +€47,596 | +53.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €50,184 | €48,313 | -€1,871 | -3.7% |
| Other operating charges | 640/8 | €7,748 | €6,885 | -€863 | -11.1% |
| Gross operating margin | 9900 | €308,603 | €352,515 | +€43,912 | +14.2% |
| Operating profit (loss) | 9901 | €160,951 | €160,001 | -€950 | -0.6% |
| Financial income | 75/76B | €2,383 | €1,571 | -€812 | -34.1% |
| Recurring financial income | 75 | €2,383 | €1,571 | -€812 | -34.1% |
| Financial charges | 65/66B | €3,833 | €3,227 | -€606 | -15.8% |
| Recurring financial charges | 65 | €3,833 | €3,227 | -€606 | -15.8% |
| Profit (loss) for the period before taxes | 9903 | €159,502 | €158,346 | -€1,157 | -0.7% |
| Income taxes | 67/77 | €45,088 | €37,724 | -€7,365 | -16.3% |
| Profit (loss) for the period | 9904 | €114,414 | €120,622 | +€6,208 | +5.4% |
| Profit (loss) for the period to be appropriated | 9905 | €114,414 | €120,622 | +€6,208 | +5.4% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 13 October 2026 via checked.be.